Virtual Medicinal Product (VMP)
-
Bevacizumab 400mg/16ml solution for infusion vials
Name Details
Current Name
Bevacizumab 400mg/16ml solution for infusion vials
|
Start Date
14-01-2009
|
End Date
|
Previous Name
Bevacizumab 400mg/16ml solution for injection vials
|
Start Date
23-03-2005
|
End Date
13-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 16
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01FG01
BNF |
Current BNF
08010500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010500
|
Start Date
03-11-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
35911211000001106 |
19-10-2018 |
|
409410005 |
09-08-2005 |
18-10-2018 |
9154611000001105 |
23-03-2005 |
08-08-2005 |
VMP Ingredients
VMP ingredients table
Bevacizumab |
Based on Ingredient Substance |
|
25 mg |
1 ml |
Name
Bevacizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Bevacizumab
-
VMP
(Current) Bevacizumab 400mg/16ml solution for ...
Virtual Medicinal Product Pack (VMPP) Information